European Risk Minimisation, Implementation and Evaluation 2015

SMi Group are proud to introduce its masterclass taking place on 9th March 2015 in Central London, European Risk Minimisation, Implementation and Evaluation.

This masterclass provides the opportunity to learn about:

. The expectations of EU regulators
. How to identify, develop and implement additional risk minimization measures for new and old drugs
. How to devise evaluation studies and consider their aftermath

European Risk Minimisation, Implementation and Evaluation will be hosted by Oxon, OXON is a London/Madrid based CRO with pan-European reach that specialises in Epidemiology, Safety (PASS and risk minimisation, statistical signal analysis, benefit-risk analysis), HEOR and Meta-analysis.

Why you should attend:

. Discuss your challenges in risk minimisation
. Analyse the principles of risk minimisation
. Gain insight into the benefits of using an evidence-based toolkit
. Evaluate the effectiveness of planned and ongoing risk minimisation

Hosted by: Nawab Qizilbash, Director, OXON Epidemiology and Noelia Alfaro, Manager of Qualitative Research, OXON Epidemiology

HOW TO REGISTER
Book before 30th January & save £100